SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-005455
Filing Date
2022-02-25
Accepted
2022-02-25 08:57:43
Documents
14
Period of Report
2022-02-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38931
2 ex99-1.htm EX-99.1 25421
3 ex99-1_001.jpg GRAPHIC 3003
  Complete submission text file 0001493152-22-005455.txt   244803

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vbiv-20220225.xsd EX-101.SCH 3042
5 XBRL LABEL FILE vbiv-20220225_lab.xml EX-101.LAB 34476
6 XBRL PRESENTATION FILE vbiv-20220225_pre.xml EX-101.PRE 22601
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3405
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 22674777
SIC: 2834 Pharmaceutical Preparations